Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura

被引：5
|
作者：
Tsai, HM [1 ]
机构：
[1] Montefiore Med Ctr, Div Hematol, Bronx, NY 10467 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2003年 / 1卷 / 09期
关键词：
D O I：
10.1046/j.1538-7836.2003.t01-1-00377.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2038 / 2040
页数：3
相关论文
共 50 条
  • [41] Thrombotic thrombocytopenic purpura and ADAMTS13
    Kokame, Koichi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 19 - 20
  • [42] Thrombotic Thrombocytopenic Purpura with Severe ADAMTS-13 Deficiency in a Patient with Antiphospholipid Antibodies and Charcot-Marie-Tooth Disease
    Kosaka, Mayu
    Takahashi, Naoto
    Saitoh, Hirobumi
    Masai, Rie
    Ito, Mitsugu
    Sato, Ryuta
    Wakui, Hideki
    Sawada, Kenichi
    INTERNAL MEDICINE, 2011, 50 (05) : 487 - 493
  • [43] Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo
    Shelat, S. G.
    Smith, P.
    Ai, J.
    Zheng, X. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (08) : 1707 - 1717
  • [44] Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children
    Chantal Loirat
    Jean-Pierre Girma
    Céline Desconclois
    Paul Coppo
    Agnès Veyradier
    Pediatric Nephrology, 2009, 24 : 19 - 29
  • [45] ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
    Bettoni, G.
    Palla, R.
    Valsecchi, C.
    Consonni, D.
    Lotta, L. A.
    Trisolini, S. M.
    Mancini, I.
    Musallam, K. M.
    Rosendaal, F. R.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (08) : 1556 - 1565
  • [46] Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children
    Loirat, Chantal
    Girma, Jean-Pierre
    Desconclois, Celine
    Coppo, Paul
    Veyradier, Agnes
    PEDIATRIC NEPHROLOGY, 2009, 24 (01) : 19 - 29
  • [47] Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
    Scully, Marie
    Knoebl, Paul
    Kentouche, Karim
    Rice, Lawrence
    Windyga, Jerzy
    Schneppenheim, Reinhard
    Hovinga, Johanna A. Kremer
    Kajiwara, Michiko
    Fujimura, Yoshihiro
    Maggiore, Caterina
    Doralt, Jennifer
    Hibbard, Christopher
    Martell, Leah
    Ewenstein, Bruce
    BLOOD, 2017, 130 (19) : 2055 - 2063
  • [48] Plasma therapy in thrombotic thrombocytopenic purpura:: Review of the literature and the bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency
    Fontana, S
    Hovinga, JAK
    Studt, JD
    Alberio, L
    Lämmle, B
    Taleghani, BM
    SEMINARS IN HEMATOLOGY, 2004, 41 (01) : 48 - 59
  • [49] Recombinant ADAMTS 13 Concentrate in Thrombotic Thrombocytopenic Purpura
    Cataland, Spero R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (09) : 430 - 432
  • [50] News in thrombotic thrombocytopenic purpura and ADAMTS13
    Joly, Berangere
    Beranger, Nicolas
    Benhamou, Ygal
    Coppo, Paul
    Veyradier, Agnes
    HEMATOLOGIE, 2021, 27 (04): : 188 - 199
12345